VHCP Management II’s Adverum Biotechnologies ADVM Stock Holding History

VHCP Management II’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$4.42M	Buy	+38,362	New	+$3.38M	1.16%	12
2017 Q4	–	Sell	-28,000	Closed	-$1.02M	–	19
2017 Q3	$1.02M	Hold	28,000	–	–	0.28%	19
2017 Q2	$700K	Hold	28,000	–	–	0.28%	18
2017 Q1	$756K	Hold	28,000	–	–	0.31%	18
2016 Q4	$812K	Hold	28,000	–	–	0.39%	21
2016 Q3	$1.15M	Hold	28,000	–	–	0.59%	22
2016 Q2	$885K	Hold	28,000	–	–	0.53%	21
2016 Q1	$1.45M	Hold	28,000	–	–	0.95%	20
2015 Q4	$2.67M	Buy	+28,000	New	+$2.46M	2.19%	13

Other funds holding ADVM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Kam Lawrence $97.4M AUM

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VHCP Management II's ADVM Position: Q4 2019 in Review

VHCP Management II opened a new position in Adverum Biotechnologies (ADVM) in Q4 2019: 38,362 shares worth $4.42M. The stake represents 1.16% of the portfolio and ranks #12 among its holdings. This is a return to the name: VHCP Management II previously reported a position in ADVM as recently as Q3 2017.

VHCP Management II first reported a position in ADVM in Q4 2015 and has held it in 9 quarters since. 116 funds tracked by Wall St. Rank hold ADVM as of Q4 2019.

VHCP Management II held 38,362 shares of Adverum Biotechnologies worth $4.42M as of Q4 2019.
Adverum Biotechnologies was a new VHCP Management II position in Q4 2019.
Adverum Biotechnologies made up 1.16% of VHCP Management II's portfolio in Q4 2019, its #12 holding.
VHCP Management II first reported a position in Adverum Biotechnologies in Q4 2015 and has held it in 9 quarters since.
116 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.